MARTINGALE ASSET MANAGEMENT L P - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 94 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARTINGALE ASSET MANAGEMENT L P ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,829,529
-23.4%
39,781
-4.3%
0.04%
-19.1%
Q2 2023$2,388,626
+51.1%
41,563
-1.4%
0.05%
+56.7%
Q1 2023$1,581,300
+22.3%
42,168
-8.6%
0.03%
+20.0%
Q4 2022$1,293,067
-29.8%
46,148
-29.6%
0.02%
-32.4%
Q3 2022$1,842,000
-29.0%
65,536
-12.1%
0.04%
-21.3%
Q2 2022$2,596,000
-13.1%
74,574
-10.3%
0.05%
+4.4%
Q1 2022$2,986,000
+25.6%
83,136
-18.5%
0.04%
+50.0%
Q4 2021$2,377,000
+13.6%
102,002
-7.3%
0.03%
+11.1%
Q3 2021$2,092,000
+109.8%
109,987
+122.6%
0.03%
+145.5%
Q2 2021$997,000
+179.3%
49,417
+154.5%
0.01%
+175.0%
Q1 2021$357,000
-10.3%
19,417
-1.5%
0.00%
-20.0%
Q4 2020$398,000
-79.3%
19,717
-80.8%
0.01%
-78.3%
Q3 2020$1,923,000
-59.8%
102,517
-51.8%
0.02%
-58.9%
Q2 2020$4,781,000
+51.3%
212,830
+0.0%
0.06%
+33.3%
Q1 2020$3,159,000
-21.9%
212,817
+1.5%
0.04%
+2.4%
Q4 2019$4,045,000
-4.9%
209,638
-2.2%
0.04%
-4.7%
Q3 2019$4,254,000
+0.4%
214,444
+6.8%
0.04%
-2.3%
Q2 2019$4,238,000
-5.9%
200,738
-8.9%
0.04%
-10.2%
Q1 2019$4,505,000
+11.1%
220,438
+8.2%
0.05%
-9.3%
Q4 2018$4,055,000
+99.5%
203,746
+92.9%
0.05%
+125.0%
Q3 2018$2,033,000
+47.0%
105,629
+44.9%
0.02%
+14.3%
Q3 2016$1,383,000
+32.6%
72,903
+12.7%
0.02%
+23.5%
Q2 2016$1,043,000
-3.7%
64,700
-28.3%
0.02%
-19.0%
Q1 2016$1,083,000
-15.7%
90,2250.0%0.02%
-25.0%
Q4 2015$1,284,000
+19.6%
90,225
-1.7%
0.03%
+7.7%
Q3 2015$1,074,000
+115.7%
91,822
+224.4%
0.03%
+116.7%
Q2 2015$498,00028,3090.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders